SAN DIEGO, May 09, 2018 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) will hold its 2018 Annual General Meeting of Stockholders (the “AGM”) on Wednesday, May 16, 2018 at 4:00 p.m. US PDT (which is Thursday, 17 May 2018 at 9:00 a.m. AEST). The meeting will be held at the offices of DLA Piper LLP (US), 4365 Executive Drive, Suite 1100, San Diego, California 92121.
The AGM will be audiocast and may be accessed within Australia by dialing 1800 005 989 five minutes prior to the scheduled start time. Callers in the United States and Canada may access the call by dialing 1-877-312-5413. The conference ID is 7558037 for all locations.
If you reside outside of Australia, the United States, or Canada, or if you prefer to access the call through our website, please visit “Events & Presentations” under the “Investors” section of our website at www.revamedical.com, and click on the “listen to webcast” link. A live webcast and transcript of the call will also be available on our website.
About REVA Medical
REVA Medical is a medical device company focused on the development and commercialization of bioresorbable polymer technologies for vascular applications. The Company’s lead products are the Fantom and Fantom Encore bioresorbable vascular scaffolds for the treatment of coronary artery disease. REVA is located in San Diego, California, USA and employs over 50 people in the U.S. and Europe.
Fantom and Fantom Encore are trademarks of REVA Medical, Inc.
|Investor & Media Enquiries:||Investor Enquiries:||Media Enquiries:|
|REVA Medical, Inc.||Inteq Limited||Buchan Consulting|
|Brandi Roberts||Kim Jacobs||Rebecca Wilson|
|Chief Financial Officer||+61 438 217 279||+61 3 9866 4722|
|+1 858-966-3003||Andrew Cohen|
|Cheryl Liberatore||+61 408 333 452|